Acquisition parameters for oncologic imaging with a new SPECT/multislice CT scanner

Molecular Imaging and Biology

Volumn 12, Issue 2, 2010, Pages 110-138

  Núñez, Rodolfo ^a   Erwin, William D ^b   Wendt III, Richard E ^b   Stachowiak, Anne ^a   Mar, Martha ^b   Stevens, Donna ^b   Madewell, John E ^b   Yeung, Henry W ^a   Macapinlac, Homer A ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Acquisition parameters; Oncologic imaging; SPECT multislice CT scanner

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; (3 IODOBENZYL)GUANIDINE I 131; FLUORODEOXYGLUCOSE F 18; GALLIUM 67; IBRITUMOMAB TIUXETAN; IODINE 131; LEXIDRONAM SAMARIUM SM 153; MACROSALB TC 99M; PENTETATE INDIUM IN 111; PENTETREOTIDE; PENTETREOTIDE IN 111; TOSITUMOMAB I 131; YTTRIUM 90;

BONE CANCER; BONE SCINTISCANNING; BRAIN CANCER; COMPUTED TOMOGRAPHY SCANNER; DIAGNOSTIC VALUE; FOLLICULAR LYMPHOMA; HUMAN; IMAGE DISPLAY; IMAGE PROCESSING; IMAGE QUALITY; IMAGE RECONSTRUCTION; LUNG CANCER; LUNG SCINTISCANNING; LYMPH NODE METASTASIS; LYMPHOSCINTIGRAPHY; MALIGNANT NEOPLASTIC DISEASE; MEDICAL ASSESSMENT; MULTIDETECTOR COMPUTED TOMOGRAPHY; NEUROENDOCRINE TUMOR; PARATHYROID ADENOMA; PARATHYROID SCINTISCANNING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; SCINTILLATION CAMERA; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THREE DIMENSIONAL IMAGING; THYROID CANCER; TREATMENT PLANNING; WHOLE BODY SCINTISCANNING;

HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; NEOPLASMS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED;

EID: 77953542141     PISSN: 15361632     EISSN: 18602002     Source Type: Journal    
DOI: 10.1007/s11307-009-0266-4     Document Type: Review

References (61)

1. Von Schulthess GK, Steinert HC, Hany TF (2006) Integrated PET/CT: current applications and future directions. Radiology 2:405-422
2. Lang TF, Hasegawa BH, Liew SC et al (1992) Description of a prototype emission-transmission CT imaging system. J Nucl Med 33:1881-1887
3. O'Connor MK, Kemp BJ (2006) Single-photon emission computed tomography/computed tomography: basic instrumentation and innovations. Semin Nucl Med 36:258-266
4. Ruf J, Seehofer D, Denecke T et al (2007) Impact of image fusion and attenuation correction by SPECT-CT on the scintigraphic detection of parathyroid adenomas. Nuklearmedizin 46:15-21
5. Eschman SM, Horger M, Phannenberg AC et al (2002) Improved specificity of bone scintigraphy by combined transmission and emission tomography (TET). J Nucl Med 43:340P
6. Ingui CJ, Shah NP, Oates MF (2006) Endocrine neoplasm scintigraphy: added value of fusing SPECT/CT images compared with traditional side-by-side analysis. Clin Nucl Med 31:665-672
7. 111In WBC scintigraphy. J Nucl Med 44:341P-342P
8. Dewaraja YK, Wilderman SJ, Ljungberg M, Koral KF, Zasadny K, Kaminski MS (2005) Accurate dosimetry in 131I radionuclide therapy using patient-specific, 3-dimensional methods for SPECT reconstruction and absorbed dose calculation. J Nucl Med 46:840-849
9. Coleman DD, RE GMJ et al (2006) Procedure guideline for SPECT/CT imaging 1.0. J Nucl Med 47:1227-1234
10. Even-Sapir E, Fluseser G, Lerman H, Lievshitz G, Metser U (2007) SPECT/multislice low-dose CT: a clinically relevant constituent in the imaging algorithm of nononcologic patients referred for bone scintigraphy. J Nucl Med 48:319-324
11. Nakahara T, Shigematsu N, Fujii M et al (2006) Value of CT thallium-201 SPECT fusion imaging over SPECT alone for detection and localization of nasopharyngeal and maxillary cancers. Am J Roentgenol 187:825-829
12. Denecke T, Hildebrandt B, Lehmkuhl L et al (2005) Fusion imaging using a hybrid SPECT/CT camera improves port perfusion scintigraphy for control of hepatic arterial infusion of chemotherapy in colorectal cancer patients. Eur J Nucl Med Mol Imaging 32:1003-1010
13. Keidar Z, Israel O, Krausz Y (2003) SPECT/CT in tumor imaging: technical aspects and clinical applications. Semin Nucl Med 33:205-218
14. Even-Sapir E, Keidar Z, Sachs J et al (2001) The new technology of combined transmission and emission tomography in evaluation of endocrine carcinomas. J Nucl Med 42:998-1004
15. Pfanneberg AC, Eschmann SM, Horger M et al (2003) Benefit of anatomical functional image fusion in the diagnostic work-up of neuroendocrine neoplasms. Eur J Nucl Med Mol Imaging 30:835-843
16. Schillaci O (2004) Functional-anatomical image fusion in neuroendocrine tumors. Cancer Biother Radiopharm 19:129-134
17. Delbeke D, Coleman RE, Guiberteau MJ et al (2006) Procedure guideline for SPECT/CT imaging 1.0. J Nucl Med 47:1227-1234
18. Schillaci O, Filippi L, Danieli R, Simonetti G (2007) Single-photon emission computed tomography/computed tomography in abdominal diseases. Semin Nucl Med 37:48-61 (Pubitemid 44854755)
19. Schillaci O, Filippi L, Manni C, Santoni R (2007) Single-photon emission computed tomography/computed tomography in brain tumors. Semin Nucl Med 37:34-47 (Pubitemid 44854759)
20. Utsunomiya D, Shiraishi S, Imuta M et al (2006) Added value of SPECT/CT fusion in assessing suspected bone metastasis: comparison with scintigraphy alone and nonfused scintigraphy and CT. Radiology 238:264-271
21. Romer W, Nomayr A, Uder M, Bautz W, Kuwert T (2006) SPECT-guided CT for evaluating foci of increased bone metabolism classified as indeterminate on SPECT in cancer patients. J Nucl Med 47:1102-1106
22. Even-Sapir E, Flusser G, Lerman H et al (2007) SPECT/multislice low-dose CT: a clinical relevant constituent in the imaging algorithm of nononcologic patients referred for bone scintigraphy. J Nucl Med 48:319-324
23. Núñez R, Namwongprom S, Stachowiak A, Mar M, Won KS, Macapinlac HA (2006) Value of bone scintigraphy with a hybrid SPECT/multislice CT scanner to assess for osseous metastases. Eur J Nucl Med Mol Imaging 33(Supplement 2):S275
24. Mawlawi O, Erwin W, Pan T et al (2007) What is optimal minimum whole body bone SPECT scan duration that can replace planar bone scintigraphy? J Nucl Med 48(Supplement 2):120P
25. 99mTc-sestamibi SPECT/CT over conventional SPECT in the evaluation of parathyroid adenomas or hyperplasia. J Nucl Med 46:248-252
26. Krausz Y, Bettman L, Guralnik L et al (2006) Technetium-99 m-MIBI SPECT/CT in primary hyperparathyroidism. World J Surg 30:76-83
27. 99mTc-sestamibi parathyroid scintigraphy. J Nucl Med 48:1084-1089
28. Núñez R, Namwongprom S, Kim EE et al (2006) Additional value of parathyroid scintigraphy with a hybrid SPECT/multislice CT scanner in patients with primary hyperparathyroidism. World J Nucl Med 5 (supplement 1):S71
29. 111In-pentetreotide in assessment of neuroendocrine tumors. Clin Endocrinol 59:565-573
30. 99mTc-HYNIC-Tyr(3)-octreotide SPECT and diagnostic CT using and immobilisation device with external markers in patients with endocrine tumors. Eur J Nucl Med Mol Imaging 32:1440-1451
31. Hillel PG, van beek EJ, Taylor C et al (2006) The clinical impact of a combined gamma camera/CT imaging system on somatostatin receptor imaging of neuroendocrine tumors. Clin Radiol 61:579-587
32. 131I- SPECT/CT images obtained with an integrated system in the follow-up of patients with thyroid carcinoma. Eur J Nucl Med Mol Imaging 31:1435-1442
33. Ruf J, Lehmkuhl L, Bertram H et al (2004) Impact of SPECT and integrated low-dose CT after radioiodine therapy on the management of patients with thyroid carcinoma. Nucl Med Commun 25:1177-1182
34. Yamamoto Y, Nishiyama Y, Monden T, Matsumura Y, Satoh K, Ohkawa M (2003) Clinical usefulness of fusion of 131-I SPECT and CT images in patients with differentiated thyroid carcinoma. J Nucl Med 44:1905-1910
35. Lerman H, Mester U, Lievshitz G, Sperber F, Shneebaum S, Even-Sapir E (2006) Lymphoscintigraphic sentinel node identification in patients with breast cancer: the role of SPECT/CT. Eur J Nucl Med Mol Imaging 33:329-337
36. Lerman H, Lievshitz G, Zak O, Mester U, Schneebaum S, Even-Sapir E (2007) Improved sentinel node identification by SPECT/CT in overweight patients with breast cancer. J Nucl Med 48:201-206
37. Even-Sapir F, Lerman H, Lieshitz G et al (2003) Lymphoscintigraphy for sentinel node mapping using a hybrid SPECT/CT system. J Nucl Med 44:1413-1420
38. Khafif A, Schneebaum S, Fliss DM et al (2006) Lymphoscintigraphy for sentinel node mapping using a hybrid single photon emission CT (SPECT)/CT system in the oral cavity squamous cell carcinoma. Head Neck 28:874-879
39. Bilde A, Von Buchwald C, Mortensen J et al (2006) The role of SPECT-CT in the lymphoscintigraphic identification of sentinel nodes in patients with oral cancer. Acta Otoraryngol 126:1096-1103
40. Keski-Santi H, Matzke S, Kauppinen T, Tornwall J, Atula T (2006) Sentinel lymph node mapping using SPECT-CT fusion imaging in patients with oral cavity squamous cell carcinoma. Eur Arch Otorhino-laryngol 263:1008-1012
41. Husarik DB, Steinert HC (2007) Single-photon emission computed tomography/computed tomography for sentinel node mapping in breast cancer. Semin Nucl Med 37:29-33
42. 18F-FDG PET and PET/CT in fever of unknown origin. J Nucl Med 48:35-45
43. 111In-labelled leukocyte scintigraphy for diagnosis of infection. J Nucl Med 47:587-594
44. 123I-MIBG scintigraphy. Nuklearmedizin 43:164-170
45. 123I-MIBG SPECT/CT. J Nucl Med 47:1635-1642
46. Even-Sapir E, Keidar Z, Sachs J et al (2001) The new technology of combined transmission and emission tomography in evaluation of endocrine neoplasms. J Nucl Med 42:998-1004
47. Soddee DB, Nelson AD, Faulhaber PF et al (2005) Update on fused capromab pendetide imaging of prostate cancer. Clin Prostate Cancer 3:230-238
48. Seltzer MA, Barbaric Z, Belldegrun A et al (1999) Comparison of helical computed tomography, positron emission tomography and monoclonal antibody scans for evaluation of lymph node metastases in patients with prostate specific antigen relapse after treatment for localized prostate cancer. J Urol 162:1322-1328
49. Schettino CJ, Kramer EL, Noz ME et al (2004) Impact of fusion of indium-111 capromab pendetide volume data sets with those from MRI or CT in patients with recurrent prostate cancer. Am J Roentgenol 183:519-524
50. Manyak MJ, Hinkle GH, Olsen JO et al (1999) Immunoscintigraphy with indium-111-capromab pendetide: evaluation before definitive therapy in patients with prostate cancer. Urology 54:1058-1063
51. 103Pd implantation for patients with intermediate and unfavorable risk prostate adenocarcinoma. Brachytherapy 2:215-222
52. Gayed IW, Chang J, Kim EE et al (2008) Lung perfusion imaging can risk stratify lung cancer patients for the development of pulmonary complications after chemoradiation. J Thorac Oncol 8:858-864
53. Kadrmas DJ, Frey EC, Karimi SS et al (1998) Fast implementations of reconstruction-based scatter compensation in fully 3D SPECT image reconstruction. Phys Med Biol 43:857-873
54. Royal HD, Brown ML, Drum DE et al (1998) Procedure guideline for hepatic and splenic imaging. Society of Nuclear Medicine. J Nucl Med 39:1114-1116
55. Ziesman HA, Silverman PM, Patterson J et al (1991) Improved detection of small cavernous hemangiomas of the liver with high resolution three headed SPECT. J Nucl Med 32:2086-2091
56. Schillaci O, Danieli R, Manni C et al (2004) Technetium-99m-labelled red blood cell imaging in the diagnosis of hepatic haemangiomas: the role of SPECT/CT with a hybrid camera. Eur J Nucl Mol Imaging 31:1011-1015
57. Horger M, Eschemann SM, Lengerke C et al (2003) Improved detection of splenosis in patients with haematological disorders: the role of combined transmission-emission tomography. Eur J Nucl Med Mol Imaging 30:316-319
58. Delman T, Shah NP, Oates ME (2006) Thallium/gallium scintigraphy revisited: added value of SPECT/CT/MR image fusion for characterizing brain lesions. Clin Nucl Med 31:118
59. Filippi L, Schillaci O, Santoni R et al (2006) Usefulness of SPECT/CT with a hybrid camera for the functional anatomical mapping of primary brain tumors by [Tc99m] tetrofosmin. Cancer Biother Radiopharm 21:41-48
60. Sulkin TV, Cousens C (2008) SPECT/CT cerebral perfusion scintig-raphy; is the low dose CT component of diagnostic value? Clin Radiol 63:289-298
61. Hayashi M, Deguchi J, Utsunomiya K et al (2005) Comparison methods of attenuation and scatter correction in brain perfusion SPECT. J Nucl Med Technol 33:224-229